Study: GLP-1 drugs like Ozempic linked to 11x higher anesthesia regurgitation risk

A British study reports that patients on GLP-1 receptor agonists such as Ozempic face an 11-fold higher risk of regurgitation during anesthesia, a complication that can lead to aspiration. The finding is based on observational data and requires corroboration, but it signals a potential new safety consideration for perioperative care. This matters as GLP-1 drug use expands globally, affecting surgical risk management protocols.